Main Uses of Letrox 100

Letrox 100 is a medication used primarily for thyroid hormone replacement therapy. It contains levothyroxine sodium, a synthetic version of the hormone thyroxine (T4), which is naturally produced by the thyroid gland.

Treatment of Hypothyroidism

The primary application of this medication is the treatment of hypothyroidism, a condition where the thyroid gland does not produce sufficient amounts of thyroid hormones. By replacing the missing hormone, the medication helps restore the body's metabolic balance. This applies to various forms of the condition, including:

• Primary hypothyroidism: Originating from the thyroid gland itself.
• Secondary or tertiary hypothyroidism: Resulting from issues with the pituitary gland or hypothalamus.
• Post-surgical recovery: Replacement therapy following the partial or total removal of the thyroid gland (thyroidectomy).
• Post-radiation therapy: Use after treatment involving radioactive iodine.

Thyroid-Stimulating Hormone (TSH) Suppression

Letrox 100 is utilized to suppress the secretion of thyroid-stimulating hormone (TSH) from the pituitary gland. This suppression is a key component in the management of specific thyroid disorders, such as:

• Euthyroid Goiter: Treating non-cancerous enlargement of the thyroid gland when hormone levels are otherwise normal.
• Thyroid Cancer Management: Used as an adjunctive therapy to inhibit TSH-dependent growth of cancerous cells following surgery or other treatments.

---

Benefits and Physiological Effects

The goal of treatment with Letrox 100 is to alleviate the symptoms associated with a thyroid hormone deficiency. Because thyroid hormones influence nearly every organ system, effective treatment can lead to several physiological benefits:

Restoration of Metabolic Rate

Thyroid hormones regulate the speed at which the body uses energy. Proper hormone levels help stabilize the basal metabolic rate, which can assist in managing symptoms like unexplained weight gain, sensitivity to cold, and generalized lethargy.

Improvement in Physical Symptoms

Patients typically experience a reduction in the physical manifestations of hypothyroidism, which may include:

• Skin and Hair Health: Reduction in skin dryness and improvement in hair texture or thinning.
• Cardiovascular Function: Normalization of heart rate and improved circulation.
• Digestive Health: Relief from chronic constipation associated with a slow metabolism.

Cognitive and Psychological Stability

Maintaining stable thyroid hormone levels is essential for mental health and cognitive function. Benefits often include improved concentration, better memory retention, and the stabilization of mood, helping to alleviate feelings of depression or mental fatigue.

Regulatory References

1. Levothyroxine: MedlinePlus Drug Information

Who Can and Cannot Use Levothyroxine Sodium (Letrox 100)

The eligibility profile for Levothyroxine Sodium, as defined by official regulatory documentation, establishes clear criteria for use and absolute contraindications.

Contraindicated Populations (Must Not Use)

Condition/Status	Restriction
Untreated Thyrotoxicosis	Absolute Contraindication
Uncorrected Adrenal Insufficiency	Absolute Contraindication
Acute Cardiac Events	Contraindicated (Acute Myocardial Infarction, Myocarditis, or Pancarditis)
Hypersensitivity	Documented allergy to the active substance or any excipients

Restricted or Conditional Use

Age and Health Status:

• Elderly Patients and those with Cardiovascular Disease must begin treatment with a lower initial dose and require careful monitoring to mitigate cardiac risks.
• Children under 5 years should use approved liquid formulations, as the use of crushed tablets is not recommended due to dosing inaccuracy.
• Patients with Panhypopituitarism or other risk factors for adrenal insufficiency must initiate corticosteroid therapy prior to starting levothyroxine.

Pregnancy and Lactation:

• Treatment must be continued throughout pregnancy, but the dose often needs to be increased due to higher hormonal requirements. Combination therapy with anti-thyroid agents is prohibited during this time.
• Use is permitted during breastfeeding.

Official Interaction Profile

The official interaction profile for the active ingredient, Levothyroxine sodium, is classified by regulatory authorities based on two main types of interactions: those that alter the drug's exposure in the body and those that modify the effects of co-administered medicines.

Interaction Type	Interacting Agents (Examples)
Reduced Gastrointestinal Absorption	Antacids (Aluminum, Calcium, Magnesium), Iron salts, Bile Acid Sequestrants, Phosphate Binders, Sucralfate.
Altered Clearance / Metabolism	Enzyme Inducers (Phenytoin, Rifampin, Phenobarbital), Estrogen-containing products (Oral Contraceptives).

Co-administration with agents that reduce absorption mandates a timing-based interaction rule: these substances must be taken at least four hours apart from Levothyroxine sodium, as stated in prescribing information. Failure to follow this regulatory constraint can lead to reduced hormone levels.

Officially documented pharmacodynamic interactions include an enhanced effect on oral anticoagulants (e.g., Warfarin) and the potential worsening of glycemic control in patients using antidiabetic agents (e.g., Insulin, Metformin). Furthermore, regulatory labels state that co-administration with Glucocorticoids is contraindicated in patients with uncorrected adrenal insufficiency.

Pro-Hormone Replacement and Cellular Activation

Letrox 100 provides a synthetic version of the pro-hormone, thyroxine (T4). This synthetic T4 is converted in the body to its active form, triiodothyronine (T3), through a process called deiodination. This process makes the active mediator, T3, available to proceed to its cellular targets.

---

Nuclear Receptor Binding and Gene Regulation

The active hormone, T3, enters the cell nucleus and binds to specific Thyroid Hormone Receptors (TRs) on the cell's DNA. This binding complex directly regulates the transcription (expression) of genes. The binding complex modifies the cell's machinery to influence the transcription of genes responsible for key cellular processes, including protein synthesis and energy use.

---

Systemic Metabolic Modulation

By regulating gene expression, the drug affects systems where specific transmitters and mediators control energy balance. This modulation of cellular energy balance adjusts the activity of metabolic pathways and influences the Basal Metabolic Rate (BMR). This action results in physiological adjustments, including those governing heart rate and thermogenesis.

How to Use Letrox 100: Official Administration Guidelines

The usage of Levothyroxine sodium, the active ingredient in Letrox 100, is governed by specific official instructions to ensure consistent absorption for long-term hormone replacement therapy. The medication is primarily administered via the oral route.

---

Administration Protocol

Feature	Official Administration Rule
Frequency	Taken once daily as a single dose.
Timing (Meal Relationship)	Must be taken on an empty stomach to prevent food-related absorption interference, specifically 30 to 60 minutes before breakfast.
Dose Titration Schedule	Treatment starts with a low initial dose, which is adjusted in small increments of 12.5 to 25 µg every 4 to 8 weeks until the optimal maintenance dose is achieved.
Duration	Levothyroxine therapy is typically a long-term or lifelong commitment for substitution purposes.

---

Population and Special Conditions

Administration protocols dictate a lower initial starting dose for patient groups who may be more sensitive, such as older adults or those with known cardiovascular conditions. Pediatric dosing is based on body weight and often requires a higher dose per kilogram.

For consistent hormone delivery, the dose must be taken at the same time each day. Official instructions also state that the dose must be separated by at least 4 hours from certain medications and supplements, including calcium and iron preparations, as these can interfere with Levothyroxine absorption. In cases of a missed dose, the general protocol is to take the dose as soon as possible, unless it is close to the next scheduled time, in which case the missed dose should be skipped.

---

Procedural Summary

The regimen is structured as a continuous daily process involving a single oral dose taken on an empty stomach, separated from breakfast and specific supplements. These requirements establish the standardized protocol essential for the predictable and stable administration of the hormone.

Research evidence / Overview of Studies for Letrox 100

Evidence for Substitution in Overt Hypothyroidism

The evidence base for this primary use is long-established, relying on historical pivotal trials and extensive observational cohorts. Researchers primarily examined the effect on biomarker normalization (TSH and FT4 levels) and how systemic symptoms like fatigue changed over time in the observed populations. Observational data describes long-term patterns related to TSH levels. The main limitation is the lack of recent placebo-controlled RCTs; long-term research monitored the occurrence of major cardiovascular events in large, non-randomized data sets.

Evidence for TSH Suppression After Thyroid Cancer Treatment

This specialized area involves randomized controlled trials (RCTs) and retrospective cohort studies. Research examined oncologic outcomes like cancer recurrence rates and survival, and monitored the biomarker Thyroglobulin. Studies described recurrence rates observed in cohorts where different TSH suppression levels were monitored. Findings were mixed regarding the long-term effects on bone health and cardiac function, reflecting limited data from direct comparative trials.

Studies Examining Subclinical Hypothyroidism (SCH)

Research consists of numerous RCTs and associated meta-analyses. Studies explored the effect on patient-reported outcomes (quality of life, symptoms) and cardiovascular surrogate markers. While RCTs reported a consistent observation of the TSH biomarker shifting back into the normal range, findings are inconsistent regarding changes in patient-reported symptoms. Follow-up durations are typically limited (under two years), which limits insight into long-term outcomes and contributes to low certainty.

Research on Euthyroid Goiter Reduction

This research was studied for its application to reduce the size of an enlarged thyroid gland. RCTs and meta-analyses examined the measurement of Goiter/Nodule Volume change. Study reports described variable findings, with changes in volume not consistently observed across all trials. There is limited information regarding the clinical relevance of volume reduction versus the potential risks of TSH suppression in euthyroid individuals.

Long-Term Evidence, Special Populations, and Uncertainty

Long-term data primarily rely on observational cohorts tracking patterns related to TSH levels over lifespans. Research has explored outcomes in pregnant women, pediatric patients (neonates), and older adults. Overall, the main limitations include the inconsistency of findings in SCH, limited long-term data from controlled trials, and modest sample sizes in trials focusing on certain non-overt conditions. Studies help show what has been observed so far, but research does not determine whether an individual will respond similarly.

Key Studies & References

1. Levothyroxine Sodium: MedlinePlus Drug Information
2. WHO Model List of Essential Medicines (Levothyroxine Entry)

Common questions about Letrox 100 (FAQ)

Q: Is Letrox 100 used to treat Hashimoto's thyroiditis?

Official documents state that this medicine is used as replacement therapy for hypothyroidism, or an underactive thyroid. Hashimoto's thyroiditis is a common autoimmune disease that damages the thyroid gland and is one of the primary causes of hypothyroidism. Therefore, while not always listed by name, Letrox 100 is generally used to treat the resulting hormone deficiency.

Q: Is weight change a known concern when taking Letrox 100?

According to official product information, the medicine is not indicated for weight reduction and misusing it for this purpose can result in serious health issues. However, if thyroid hormone levels are not balanced, weight changes may be observed. A dose that results in excess hormone levels can be associated with weight loss, and a dose that is too low may be associated with weight gain, reflecting an imbalance.

Q: Is there an age limit for starting treatment with Letrox 100?

Official documentation indicates that the active ingredient is used across the entire lifespan, including both pediatric patients and older adults. There is no definitive age limit for starting treatment. However, specific formulations and initial dose adjustments are mandated for very young children and the elderly to ensure safe administration.

Q: How long does it typically take for Letrox 100 to show its effects?

The active ingredient in the medicine has a relatively long half-life of approximately 7 days. Studies indicate that it takes about 4 to 6 weeks for the drug to accumulate and reach stable concentrations in the body, which is known as the steady state. This time frame is consistent with the standard interval for monitoring TSH blood levels.

Q: Is it considered normal to feel no significant change after the first few weeks of taking Letrox 100?

Given that the medicine takes about 4 to 6 weeks to reach stable therapeutic levels in the bloodstream, immediate subjective changes in well-being may not be expected. Furthermore, dose adjustments are typically not assessed until 4 to 8 weeks after starting treatment, which suggests that stabilization of TSH levels is a gradual process.

Q: How does the body absorb the active substance in Letrox 100?

According to regulatory data, the active ingredient, levothyroxine, is absorbed primarily through the lining of the small intestine. It is known that this absorption process can be variable among individuals and is significantly reduced by the presence of food in the stomach. This is the primary reason why official instructions emphasize taking the medicine on an empty stomach.

Q: What is TSH, and how does Letrox 100 influence its levels?

TSH stands for Thyroid-Stimulating Hormone, which is a substance produced by the pituitary gland to signal the thyroid to produce more hormone. When a patient takes Letrox 100 (synthetic T4), it replaces the hormone the body is missing. This replacement action helps the body normalize TSH levels, which in turn reduces the excessive signaling to the thyroid gland.

Q: Why do patients sometimes receive different brands of levothyroxine for the same condition?

Regulatory documents acknowledge that different brands of levothyroxine products may not be perfectly interchangeable due to minor variations in their inactive ingredients (excipients). These differences in formulation can potentially affect absorption. For this reason, regulatory guidance requires careful TSH monitoring whenever a patient switches between brands.

Q: Does Letrox 100 contain lactose or other known allergens?

The excipient list for Letrox 100 often includes lactose monohydrate as an inactive ingredient. Official warnings note that this medicine is contraindicated for patients with certain rare hereditary problems, such as galactose intolerance.

Q: Does using other thyroid medications alongside Letrox 100 pose a problem?

Official documents state that combination therapy with levothyroxine and anti-thyroid agents (used to treat an overactive thyroid) is generally prohibited during pregnancy. Outside of pregnancy, levothyroxine products are typically used as monotherapy, and any co-administration requires careful specialist evaluation.

Q: Are there specific foods that should be avoided when taking Letrox 100?

Regulatory documents specify that the absorption of the active ingredient may be reduced by certain dietary items, including soy-containing products and high-fiber meals. Because of this interaction, separation in administration time from these specific foods is typically advised.

Q: Can Letrox 100 be taken with coffee?

Official instructions require that the dose be taken with water only and on an empty stomach. Taking the medicine with beverages other than water, such as coffee, is described in medical literature as potentially interfering with its absorption. Adherence to the administration protocol is described as critical for achieving consistent dosing.

Q: Are there specific classes of antibiotics that are known to interact with Letrox 100?

Official documents have described specific interactions with certain classes of medicines. This includes the fluoroquinolone class of antibiotics, which can affect how the body uses the thyroid hormone. Regulatory information advises that this type of interaction may require careful monitoring and potential dose adjustment.

Q: What is the expected timeframe for feeling symptom improvement after starting treatment?

While blood levels (TSH) become stable within about 4 to 6 weeks, the experience of symptom relief is gradual. The timeframe for feeling clinical improvement depends on the individual and the severity of the initial hormone deficiency. Clinical literature notes that noticeable changes in symptoms can be gradual and may take several weeks or longer.

Q: Is there official information regarding the sudden discontinuation of Letrox 100?

For most patients, treatment with the active ingredient in Letrox 100 is intended to be lifelong. Abruptly stopping the medicine is generally described by official sources as leading to a reoccurrence of the symptoms of hypothyroidism, which is the condition the medicine is intended to treat.

Q: Is Letrox 100 designed to be swallowed whole or can it be dissolved?

The tablet is generally intended for oral ingestion. However, administration instructions for infants, where precision dosing is critical, detail that the tablet may be crushed and mixed with a small amount of water for immediate use.

Official Storage and Disposal Requirements

Regulatory documents mandate specific conditions to maintain the stability and potency of Levothyroxine sodium tablets.

Condition	Regulatory Requirement
Temperature	Store at or below 25°C (77°F).
Protection	Keep in the original package to protect from light and moisture.
Safety	The medicine must be kept out of the sight and reach of children.

The product must remain in its original container to preserve protection from environmental factors. All unused medicinal product or waste material must be disposed of in accordance with local requirements, which often means utilizing pharmaceutical take-back programs.